Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.250
+0.100 (4.65%)
At close: Dec 5, 2025, 4:00 PM EST
2.239
-0.011 (-0.51%)
After-hours: Dec 5, 2025, 7:20 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $8.55 million as of December 5, 2025. Its market cap has increased by 36.52% in one year.
Market Cap
8.55M
Enterprise Value
2.93M
1-Year Change
36.52%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $8.55M, a decrease of -99.25%. That is a compound annual growth rate of -66.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.55M | 35.73% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.66B |
| Johnson & Johnson | 487.93B |
| AbbVie | 404.02B |
| UnitedHealth Group | 301.60B |
| AstraZeneca | 279.81B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.75B |
| Abbott Laboratories | 216.96B |